The Maximon Longevity Prize for Translational Research awards outstanding breakthrough research in the field of longevity that can be translated for clinical or non-clinical applications and has the potential to substantially increase health span or life span of humans.
The award focuses on research that already has a proof of concept in pre-clinical lab studies to have a significant impact on the health optimization or longevity.
Maximon is on a mission to extend the health span and to allow people to be fit, healthy and happy until high-age.
We are accelerating longevity research by giving exceptional researchers the resources they need to expand their work and invest in new products and services geared to a longevity-society.
Maximon pledges 50 000 CHF for the winner and commits to attracting more donors and sponsors to further improve the award.
The prize recipient will also receive additional benefits from sponsors such as:
Personalized longevity program sponsored by Biolytica at the value of 20 000 CHF
One-year subscription for science-based longevity supplements supplied by AVEA at the value of 5 000 CHF
1st of March
10th of September
29th of September
25th of September
Longevity prize launch.
Applications are open
Application window is closed
End of Evaluation
Award Ceremony at the LIC Gala Dinner
We've welcomed applications from all academic/non-profit researchers, inventors, scientists, students or startup founders who either published breakthrough research, hold the patent or are in very advanced stages of research.
Application window has closed on September 10th.